Inhibition of TLR4-dependent allergic inflammatory response by Asialoglycoprotein receptor (Asgr1) glycan ligands
Single Step Reaction, No Need of Genetic Modification
Collaboration opportunity for biomolecule structure analysis
Anti-cell death, anti-fibrosis and induced-regeneration in fulminant hepatic failure and many kinds of Intractable liver diseases.
Potential application for Hepatic Encephalopathy and Urea Cycle Disorder
Fusion protein drug with RAS-binding domain and cell-permeable peptide blocks binding between RAS-GTP and RAS-effectors.
Original method and hepatocyte reproduced hepatobiliary function
Blocking C16orf74 dimerization suppresses pancreatic cancer growth and invasion.
RANKL fragment peptides treat psoriasis with reduced expression of inflammatory cytokines through Toll-like receptor 7/8 (TLR7/8) signaling pathway.
Fragmentation of RANKL Eliminates Side-effect while Boosting Effect.